YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia ...Middle East

SHANGHAI, April 28, 2025 /PRNewswire/ -- YolTech Therapeutics Co.,Ltd, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, announced promising interim clinical data from an investigator-initiated trial (IIT) of YOLT-101...

Hence then, the article about yoltech announces first clinical data from ongoing investigator initiated trial of yolt 101 an in vivo base editing therapy for familial hypercholesterolemia was published today ( Monday 28/04/2025 - 08:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia )

Also on site :

• ‘Michael’ Director Antoine Fuqua On A Convo He Had With Michael Jackson, Reshoots, The Sequel & Choices Made About Pop Icon’s Controversies
• Donald Trump Tells ’60 Minutes’ About Moments Secret Service Scrambled To Get Him Out Of Hilton Ballroom: “I Wanted To See What Was Happening”
• Walmart's 'Incredibly Comfortable' $70 Corduroy Folding Sofa Is a Hosting Game-Changer and Comes in 4 Colors